Newbury Pharmaceuticals Ab Stock Return On Asset
| NEWBRY Stock | 3.38 0.08 2.31% |
Newbury Pharmaceuticals AB fundamentals help investors to digest information that contributes to Newbury Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Newbury Stock. The fundamental analysis module provides a way to measure Newbury Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Newbury Pharmaceuticals stock.
Newbury |
Newbury Pharmaceuticals AB Company Return On Asset Analysis
Newbury Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Newbury Pharmaceuticals Return On Asset | -0.16 |
Most of Newbury Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Newbury Pharmaceuticals AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Newbury Pharmaceuticals AB has a Return On Asset of -0.1617. This is 98.15% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers-Specialty & Generic industry. The return on asset for all Sweden stocks is 15.5% higher than that of the company.
Newbury Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Newbury Pharmaceuticals' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Newbury Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Newbury Pharmaceuticals by comparing valuation metrics of similar companies.Newbury Pharmaceuticals is currently under evaluation in return on asset category among its peers.
Newbury Fundamentals
| Return On Equity | -0.34 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (2.89) % | |||
| Operating Margin | (2.75) % | |||
| Current Valuation | 96.57 M | |||
| Shares Outstanding | 19.52 M | |||
| Shares Owned By Insiders | 78.64 % | |||
| Shares Owned By Institutions | 6.72 % | |||
| Price To Book | 1.86 X | |||
| Price To Sales | 25.09 X | |||
| Revenue | 5.77 M | |||
| Gross Profit | 1.56 M | |||
| EBITDA | (15.74 M) | |||
| Book Value Per Share | 3.24 X | |||
| Target Price | 8.5 | |||
| Market Capitalization | 110.88 M | |||
| Total Asset | 86.91 M | |||
| Net Asset | 86.91 M |
About Newbury Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Newbury Pharmaceuticals AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Newbury Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Newbury Pharmaceuticals AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Newbury Stock
Newbury Pharmaceuticals financial ratios help investors to determine whether Newbury Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Newbury with respect to the benefits of owning Newbury Pharmaceuticals security.